Navigation Links
PDI Reports 2013 Second Quarter Financial Results
Date:8/5/2013

PARSIPPANY, N.J., Aug. 5, 2013 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2013. Summary financial and operating highlights include:

  • Revenue increases of 34% to $37.2 million for the second quarter of 2013 and 35% to $80.2 million for the six months of 2013 compared to the same periods last year.
  • Operating loss of $(0.8) million for the second quarter of 2013 and an operating profit of $1.4 million for the six months of 2013.
  • Adjusted EBITDA (a non-GAAP financial measure) of $0.2 million for the 2013 second quarter and $3.1 million for the six months of 2013.
  • Signing of several new, multi-year sales contracts during the second quarter, totaling approximately $13.0 million, approximately $5.0 million of which is expected to be recorded in 2013.
  • Condensed Summary Statements of Continuing Operations

    ($'s in millions, expect per share data)

    2nd Quarter EndedSix Months EndedJune 30,*June 30,*2013201220132012Revenue, net$ 37.2$ 27.8$ 80.2$ 59.5Gross profit6.86.615.313.9Operating expenses:Compensation expense4.94.19.18.7Other SG&A2.82.84.85.8Total operating expenses7.76.913.914.5Operating (loss) income$ (0.8)$ (0.3)$ 1.4$ (0.5)Provision for income tax0.10.10.10.1(Loss) income from continuing operations$ (0.9)$ (0.4)$ 1.2$ (0.7)Diluted (loss) income per share from continuing operations$(0.06)$(0.03)$ 0.08$(0.05)*UnauditedCEO CommentsCommenting on the results, Nancy Lurker, chief executive officer of PDI, Inc., noted, "Revenues from contracts signed in the second half of 2012 and the first half of 2013 positively impacted our top line, resulting in revenue for the second quarter of 2013 increasing 34% to $37.2 million compared to the
    '/>"/>
    SOURCE PDI, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
    2. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    3. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
    4. Neuland Labs Reports First Quarter Fiscal Year 2014 Financial Results
    5. IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
    6. Uroplasty Reports Fiscal First Quarter 2014 Financial Results
    7. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
    8. Optimer Reports Second Quarter 2013 Financial Results
    9. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
    10. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
    11. Hanger Reports Second Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
    (Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
    (Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
    Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
    ... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
    ... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
    Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
    (Date:9/5/2015)... ... ... "I have personally had three knee-replacement surgeries on the same knee, all in ... with this idea so that I could not only support my knee comfortable as ... to comfortably and safely support the knee while recovering from surgery or injury. The ...
    (Date:9/5/2015)... ... September 05, 2015 , ... As school supply lists continue to increase and budgets continue ... for their students. William Mattar Law Offices has found a way to help with ... as well as principals and superintendents as in past years. Because of that, the ...
    (Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... According ... in the Journal of the American Dental Association presented data showing that it is ... comparing a group of pregnant women that had undergone local anesthesia with a group ...
    (Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Schmidt ... of Tanya De La Paz. , Schmidt National Law Group, a leading firm ... District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for ...
    (Date:9/4/2015)... ... September 04, 2015 , ... After wearing the same uniforms for six ... apparel. In an effort to assist the team, the Jones Agency, a locally owned ... to raise funds for the new uniforms. , As is so often the case ...
    Breaking Medicine News(10 mins):Health News:InventHelp Inventor Develops Therapeutic Knee Support (PHO-2061) 2Health News:‘Pencils 4 Schools’ Campaign 2015 Exceeds Expectations from Previous Year 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3
    ... patients who are infected with Clostridium difficile -- ... will lengthen their stay by about six days on average, ... to controlling the spread of the bacterial infection known as ... 5 in the journal CMAJ , researchers analyzed information ...
    ... M.D., M.S., assistant professor of medicine at the Indiana ... winner of the mHealth Alliance and Rockefeller Foundation,s Top ... goal is to recognize individuals who have used mobile ... outcomes particularly in the most remote areas of the ...
    ... , MONDAY, Dec. 5 (HealthDay News) -- Teenagers ... photosensitivity, or light sensitivity, researchers say. The combination ... such as flapping their hands in front of their ... Although photosensitivity occurs in up to 14 percent ...
    ... -- Children who suffer head trauma can experience headaches months after ... a new study finds. The researchers also found that the ... brain injury (TBI) than after a moderate or severe one. ... , included children aged 5 to 17 who were hospitalized ...
    ... By Alan Mozes HealthDay Reporter , SUNDAY, ... appear to face an increased risk for seizures while watching ... results did reveal that about one in five of these ... television, including nausea, headaches and dizziness. "Normal people have ...
    ... obese volunteers participating in a 12-week dietary weight-loss ... higher resting nerve activity compared to weight-loss resistant ... The Endocrine Society,s Journal of Clinical Endocrinology ... system is widely distributed throughout the body and ...
    Cached Medicine News:Health News:Common Hospital Infection Lengthens Patient Stays 2Health News:Regenstrief investigator a winner of Top 11 in 2011 Innovator Challenge 2Health News:Girls More Prone Than Boys to Headaches After Head Injury 2Health News:3-D TV Doesn't Raise Seizure Risk for Kids With Epilepsy: Study 2Health News:3-D TV Doesn't Raise Seizure Risk for Kids With Epilepsy: Study 3Health News:Nervous system activity may predict successful weight loss 2
    ... for use during laparoscopic surgery, will help ... poor vision and loss of distension due ... and aerosols from the patient's cavity. This ... powered smoke evacuator that creates a constant ...
    ... The FRECHET EXTENDER® is a new device ... and its silicone elastomer strips, it allows ... the tissues, well beyond other devices capacities. ... short term implant since it is removed ...
    Inquire...
    Inquire...
    Medicine Products: